Delivery Order SPE2DE21D0029-SPE2D626F07YT
- Not listed
- Becton, Dickinson and Company (BD), through its Infectious Disease Systems (IDS) division, was awarded a delivery order valued at $2,143.98 by the Department of Defense's Medical Supply Chain on October 1, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by October 23, 2025, and will be performed at BD's facility in Sparks Glencoe, Maryland. The award was made on a full and open competition basis without set-aside designation, reflecting...
- Becton, Dickinson and Company's Infectious Disease Systems (IDS) division was awarded a delivery order valued at $2,143.98 by the Department of Defense's Medical Supply Chain on October 7, 2025, with an ultimate completion date of October 29, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, reflecting the company's competitive standing as a large, established medical technology manufacturer. The work will be performed in Sparks Glencoe,...
- Becton, Dickinson and Company's Infectious Disease Systems division received a delivery order award on December 10, 2025, for the Kit Affirm VPIII Clinical under a fixed-price contract with economic price adjustment provisions. The award, valued at $1,361.04 with an ultimate completion date of January 2, 2026, supports the Defense Health Agency's Medical Supply Chain operations. The work will be performed in Sparks, Maryland. This delivery order was issued without a small business set-aside...
- Becton, Dickinson and Company (BD), through its Infectious Diseases Systems (IDS) division, received a delivery order valued at $1,786.65 from the Department of Defense's Medical Supply Chain on July 31, 2025. The contract is a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, reflecting BD's competitive standing as a large medical technology manufacturer. Performance will be completed by August 21, 2025, at BD's facility in Sparks Glencoe,...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems division, was awarded a delivery order valued at $3,402.60 by the Department of Defense's Medical Supply Chain on July 17, 2025, for the Kit Affirm VPIII Clinical. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 7, 2025, and will be performed in Sparks Glencoe, Maryland. The award was made on a full and open competition basis without set-aside designation, consistent...
- Becton, Dickinson and Company's Diagnostic Systems (IDS) division has been awarded a delivery order valued at $1,786.65 by the Department of Defense's Medical Supply Chain division for performance in Sparks Glencoe, Maryland. This fixed-price delivery order with economic price adjustment provisions was awarded on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract utilizes no small business set-aside designation, reflecting BD's competitive position as a large,...
- Becton, Dickinson and Company (BD), through its Infectious Diseases Systems (IDS) division, was awarded a $55,450 firm fixed-price purchase order by the Bureau of Medicine and Surgery (a Defense agency component) on September 17, 2020, for a Comprehensive Service Plan with an ultimate completion date of September 17, 2025. The contract includes an exercised option year 1 and will be performed in Silver Spring, Maryland. This award was made on a full and open competition basis without set-aside...
- Becton, Dickinson and Company's Infectious Disease Systems division received a $1,122.00 delivery order award from the Defense Department's Medical Supply Chain on December 10, 2025, for tube culture media products (specifically 7ML BD BCTC BD MGIT BRCD MYCB items) with performance completion targeted for January 2, 2026. The contract utilizes a fixed-price structure with economic price adjustment provisions and will be performed in Sparks, Maryland. This delivery order represents a child...
- On July 30, 2025, the Defense Department's Medical Supply Chain awarded a delivery order valued at $1,458.60 to Becton, Dickinson and Company (BD), IDS Division, for the procurement of 100 units of an affirmation attachment system kit. The contract utilizes fixed-price pricing with economic price adjustment provisions and carries an ultimate completion date of August 20, 2025. Performance will take place at BD's facility in Sparks Glencoe, Maryland. This delivery order was issued without a...
- Becton, Dickinson and Company's Infectious Diseases Systems (IDS) division was awarded a delivery order valued at $998,100.60 by the Defense Health Agency for BD MAX and consumables—a handheld medical device that performs nucleic acid extraction. This firm fixed-price delivery order, effective through September 18, 2028, is issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule contract. The award was made on a full and open competition basis...
- SPE2DE21D0029Indefinite Delivery Contract
- SPE2DE21D0029-SPE2D626F07YTDelivery Order
Becton, Dickinson and Company's Infectious Disease Systems (IDS) division received a delivery order award on January 14, 2026, valued at $2,722.08 for the Kit Affirm VP III Clinical product under a fixed-price contract with economic price adjustment provisions. The award, issued by the Defense Health Agency (operating under the Department of Defense), is scheduled for completion by February 5, 2026, with performance taking place in Sparks, Maryland. This delivery order represents a child award under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) or Blanket Purchase Agreement vehicle, leveraging BD's established position as a critical supplier of diagnostic equipment and laboratory supplies to federal healthcare agencies. The contract carries no small business set-aside designation, reflecting BD's competitive positioning as a large, established medical technology manufacturer. BD's Infectious Disease Systems division specializes in providing microbiology identification systems, blood culture analyzers, molecular diagnostics, and related clinical testing solutions that support military medical operations and federal healthcare delivery. The modest delivery order value indicates procurement of consumables or replacement kits rather than capital equipment, consistent with BD's role as a primary supplier of specialized diagnostic products and reagents across Department of Defense and Department of Veterans Affairs facilities. This award exemplifies the streamlined procurement process enabled through BD's extensive IDV portfolio, which allows federal healthcare agencies to issue task orders for diagnostic supplies and equipment maintenance services with minimal procurement lead time.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/13/26 |